FY17 Q2 Business Update + Appendix 4C Respiratory technology company Rhinomed Limited (ASX: RNO) is pleased to report a record unaudited half yearly result of $1.195 million. This follows another strong quarter of operational revenue of $662k. Download a full copy of the announcement here.
Summer 2016-2017 Newsletter March, 2017. Melbourne, Australia. Welcome to the first Investor Newsletter for 2017. We are pleased to report that Rhinomed has continued another solid 12 months of achieving our major milestones. At the end of 2015 Mute was only available in a little over 900 stores, 12 months later and Mute … Read more
THE LINDE GROUP (BOC LIMITED) TO DISTRIBUTE MUTE AND TURBINE 7th December, 2016. Melbourne, Australia. Rhinomed (ASX:RNO), the Australian respiratory technology company announced it has entered into a distribution and supply agreement with The Linde Group and its Australian subsidiary BOC Limited. BOC will manage logistics and distribute Rhinomed’s breathing technologies, Mute … Read more
FY16 Q4 Quarterly Activity Report + Appendix 4C October 28, 2016. Melbourne, Australia. Respiratory technology company Rhinomed Limited (ASX: RNO) is pleased to report continued good quarter on quarter growth in operational revenue during Q1, FY17. Sales Momentum continues Receipts from Customers increased to $539k (up 59% from $340k) in parallel as receipts from both … Read more
MCKESSON TO GROW US DISTRIBUTION NETWORK FOR MUTE August 1, 2016. Melbourne, Australia. Australian respiratory technology company Rhinomed (ASX:RNO) is pleased to announce the further expansion of its US distribution network through the appointment of McKesson Corporation as a wholesale distributor of the Mute snoring and sleep technology in the North American pharmacy market. … Read more
NOTICE OF 2016 ANNUAL GENERAL MEETING Date: 8 November 2016 Time: 10:00 AM AEDT Location: Tom Wills Room in the Great Southern Stand (Level 2) Melbourne Cricket Ground, Brunton Avenue, East Melbourne, VIC. Download a copy of the announcement here.
STRONG FINISH TO THE FINANCIAL YEAR July 27, 2016. Melbourne, Australia. Rhinomed (ASX: RNO), a leader in nasal respiratory technology, today announced total unaudited revenue for the FY16 financial year of $1.01m, a 134% increase over the previous year. Strong June sales of Rhinomed’s over-the-counter snoring and sleep quality product, Mute, helped Rhinomed … Read more
RHINOMED DISTRIBUTION EXTENDS TO JET.COM April 29, 2016. Melbourne, Australia. Nasal respiratory technology company Rhinomed (ASX:RNO) is pleased to announce it will begin distributing its Mute TM brand through the US online shopping channel Jet.com. Jet.com is a rapidly expanding online membership savings club that offers goods across categories such as grocery, sports … Read more
RHINOMED APPOINTS EUROPA SPORTS TO DISTRIBUTE TURBINE AND MUTE IN USA KEY HIGHLIGHTS: ● Europa Sports appointed as a distributor of Rhinomed’s devices in the USA. ● Europa is one of America’s leading distributors of health and fitness products. ● Europa to sell TurbineTM and MuteTM into sports retailers, health clubs, gyms and health … Read more
MUTE TO GO ON SALE IN WALGREENS AND DUANE READE STORES IN USA 29th March 2016. Melbourne, Australia. Australian nasal and respiratory technology company Rhinomed Ltd (ASX:RNO), is pleased to announce the launch of its MUTE snoring and sleep technology through a 107 store promotional program in the New York- based Duane Reade … Read more
Rhinomed Appoints Canadian Distributor for Mute and Turbine KEY HIGHLIGHTS: ● McArthur Medical appointed as sole distributor of Mute and Turbine devices in Canada. ● Follows successful registration of Mute and Turbine with Canada Health, the Canadian regulatory authority in December 2015. ● McArthur Medical to roll out Mute and Turbine into Canadian pharmacies … Read more
RHINOMED’S MUTE AND TURBINE TECHNOLOGY RECEIVE REGULATORY CLEARANCE FOR CANADIAN DISTRIBUTION 3rd December, 2015. Melbourne, Australia. Australian medical technology company Rhinomed Ltd (ASX:RNO) today announced it has received its Medical Device Establishment Licence (MDEL) from Health Canada for the distribution of Turbine sports breathing technology and Mute snoring and sleep technology as Class … Read more
